[ad_1]
The EU courtroom in Luxembourg Thursday dominated towards Italian plaintiffs who challenged the bloc’s determination to maneuver the distinguished European Medicines Company (EMA) from London to Amsterdam (as an alternative of Milan) after Brexit. “The choices of the representatives of the member states” on the EMA “are political acts with none binding authorized results, with the outcome that they can’t be the topic of an motion for annulment,” judges mentioned.
Learn and resolve
Get prompt entry to all articles — and 20 years of archives.
Be part of EUobserver at present
Turn into an skilled on Europe
Get prompt entry to all articles — and 20 years of archives.
14-day free trial.
… or subscribe as a bunch
[ad_2]
Source link
